Clinical trial
Rituximab Effect on Decreasing glUcoCorticoid Exposition in PolyMyalgia Rheumatica
NCT05533125 is registered in ClinicalTrials.gov with Sint Maartenskliniek as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Rituximab Effect on Decreasing glUcoCorticoid Exposition in PolyMyalgia Rheumatica
- Lead sponsor
- Sint Maartenskliniek
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 1, 2023
- Completion date
- October 29, 2025
- Enrollment
- 114 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.